Literature DB >> 16642439

Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration.

Silke Schmidt1, Michael A Hauser2, William K Scott2, Eric A Postel3, Anita Agarwal4, Paul Gallins2, Frank Wong2, Yu Sarah Chen2, Kylee Spencer5, Nathalie Schnetz-Boutaud5, Jonathan L Haines5, Margaret A Pericak-Vance2.   

Abstract

We used iterative association mapping to identify a susceptibility gene for age-related macular degeneration (AMD) on chromosome 10q26, which is one of the most consistently implicated linkage regions for this disorder. We employed linkage analysis methods, followed by family-based and case-control association analyses, using two independent data sets. To identify statistically the most likely AMD-susceptibility allele, we used the Genotype-IBD Sharing Test (GIST) and conditional haplotype analysis. To incorporate the two most important known AMD risk factors--smoking and the Y402H variant of the complement factor H gene (CFH)--we used logistic regression modeling to test for gene-gene and gene-environment interactions in the case-control data set and used the ordered-subset analysis to account for genetic linkage heterogeneity in the family-based data set. Our results strongly implicate a coding change (Ala69Ser) in the LOC387715 gene as the second major identified AMD-susceptibility allele, confirming earlier suggestions. This variant's effect on AMD is statistically independent of CFH and is of similar magnitude to the effect of Y402H. The overall effect is driven primarily by a strong association in smokers, since we observed significant evidence for a statistical interaction between the LOC387715 variant and a history of cigarette smoking. This gene-environment interaction is supported by statistically independent family-based and case-control analysis methods. We estimate that CFH, LOC387715, and cigarette smoking together explain 61% of the population-attributable risk (PAR) of AMD. The adjusted PAR percentage estimates are 20% for smoking, 36% for LOC387715, and 43% for CFH. We demonstrate, for the first time, that a genetic susceptibility coupled with a modifiable lifestyle factor such as cigarette smoking confers a significantly higher risk of AMD than either factor alone.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16642439      PMCID: PMC1474047          DOI: 10.1086/503822

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  42 in total

1.  Merlin--rapid analysis of dense genetic maps using sparse gene flow trees.

Authors:  Gonçalo R Abecasis; Stacey S Cherny; William O Cookson; Lon R Cardon
Journal:  Nat Genet       Date:  2001-12-03       Impact factor: 38.330

2.  Replication validity of genetic association studies.

Authors:  J P Ioannidis; E E Ntzani; T A Trikalinos; D G Contopoulos-Ioannidis
Journal:  Nat Genet       Date:  2001-11       Impact factor: 38.330

3.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

4.  Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease.

Authors:  Kirk E Lohmueller; Celeste L Pearce; Malcolm Pike; Eric S Lander; Joel N Hirschhorn
Journal:  Nat Genet       Date:  2003-01-13       Impact factor: 38.330

5.  Risk factors for age-related macular degeneration: Pooled findings from three continents.

Authors:  W Smith; J Assink; R Klein; P Mitchell; C C Klaver; B E Klein; A Hofman; S Jensen; J J Wang; P T de Jong
Journal:  Ophthalmology       Date:  2001-04       Impact factor: 12.079

6.  Incidence and progression rates of age-related maculopathy: the Rotterdam Study.

Authors:  C C Klaver; J J Assink; R van Leeuwen; R C Wolfs; J R Vingerling; T Stijnen; A Hofman; P T de Jong
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-09       Impact factor: 4.799

7.  Association of the apolipoprotein E gene with age-related macular degeneration: possible effect modification by family history, age, and gender.

Authors:  S Schmidt; A M Saunders; E A Postel; R M Heinis; A Agarwal; W K Scott; J R Gilbert; J G McDowell; A Bazyk; J D Gass; J L Haines; M A Pericak-Vance
Journal:  Mol Vis       Date:  2000-12-31       Impact factor: 2.367

8.  The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study.

Authors:  Redmer van Leeuwen; Caroline C W Klaver; Johannes R Vingerling; Albert Hofman; Paulus T V M de Jong
Journal:  Arch Ophthalmol       Date:  2003-04

9.  The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study.

Authors:  Ronald Klein; Barbara E K Klein; Sandra C Tomany; Karen J Cruickshanks
Journal:  Ophthalmology       Date:  2003-06       Impact factor: 12.079

10.  Age-related macular degeneration--a genome scan in extended families.

Authors:  Jacek Majewski; Dennis W Schultz; Richard G Weleber; Mitchell B Schain; Albert O Edwards; Tara C Matise; Ted S Acott; Jurg Ott; Michael L Klein
Journal:  Am J Hum Genet       Date:  2003-07-25       Impact factor: 11.025

View more
  119 in total

1.  Effects of aflibercept for ranibizumab-resistant neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Yu Kawashima; Akio Oishi; Akitaka Tsujikawa; Kenji Yamashiro; Masahiro Miyake; Naoko Ueda-Arakawa; Munemitsu Yoshikawa; Ayako Takahashi; Nagahisa Yoshimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-13       Impact factor: 3.117

Review 2.  How does the macula protect itself from oxidative stress?

Authors:  James T Handa
Journal:  Mol Aspects Med       Date:  2012-04-05

3.  Macular pigment optical density in wet age-related macular degeneration among Indians.

Authors:  R Raman; S Biswas; K Vaitheeswaran; T Sharma
Journal:  Eye (Lond)       Date:  2012-05-25       Impact factor: 3.775

4.  Analysis of single nucleotide polymorphisms in the NOS2A gene and interaction with smoking in age-related macular degeneration.

Authors:  Juan A Ayala-Haedo; Paul J Gallins; Patrice L Whitehead; Stephen G Schwartz; Jaclyn L Kovach; Eric A Postel; Anita Agarwal; Gaofeng Wang; Jonathan L Haines; Margaret A Pericak-Vance; William K Scott
Journal:  Ann Hum Genet       Date:  2010-03-31       Impact factor: 1.670

Review 5.  Age-related macular degeneration: genetic and environmental factors of disease.

Authors:  Yuhong Chen; Matthew Bedell; Kang Zhang
Journal:  Mol Interv       Date:  2010-10

6.  Dissection of chromosome 16p12 linkage peak suggests a possible role for CACNG3 variants in age-related macular degeneration susceptibility.

Authors:  Kylee L Spencer; Lana M Olson; Nathalie Schnetz-Boutaud; Paul Gallins; Gaofeng Wang; William K Scott; Anita Agarwal; Johanna Jakobsdottir; Yvette Conley; Daniel E Weeks; Michael B Gorin; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-28       Impact factor: 4.799

7.  Combined effects of complement factor H genotypes, fish consumption, and inflammatory markers on long-term risk for age-related macular degeneration in a cohort.

Authors:  Jie Jin Wang; Elena Rochtchina; Wayne Smith; Ronald Klein; Barbara E K Klein; Tripti Joshi; Theru A Sivakumaran; Sudha Iyengar; Paul Mitchell
Journal:  Am J Epidemiol       Date:  2008-12-13       Impact factor: 4.897

8.  Predictive value of VEGF A and VEGFR2 polymorphisms in the response to intravitreal ranibizumab treatment for wet AMD.

Authors:  Fernando Cruz-Gonzalez; Lucía Cabrillo-Estévez; Gloria López-Valverde; Clara Cieza-Borrella; Emiliano Hernández-Galilea; Rogelio González-Sarmiento
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-02-13       Impact factor: 3.117

Review 9.  Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.

Authors:  S Scott Whitmore; Elliott H Sohn; Kathleen R Chirco; Arlene V Drack; Edwin M Stone; Budd A Tucker; Robert F Mullins
Journal:  Prog Retin Eye Res       Date:  2014-12-05       Impact factor: 21.198

10.  Risk alleles in CFH and ARMS2 and the long-term natural history of age-related macular degeneration: the Beaver Dam Eye Study.

Authors:  Ronald Klein; Chelsea E Myers; Stacy M Meuer; Ronald E Gangnon; Theru A Sivakumaran; Sudha K Iyengar; Kristine E Lee; Barbara E K Klein
Journal:  JAMA Ophthalmol       Date:  2013-03       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.